Aktsier,
You have my terms and I am adding one. SLA must release full clinical trial details on Bio A and Ropren, just like every other biotech does with their products. There can be no truly open debate unless this occurs. They seem to believe they are above the market on this one.
December, if I don't see something today.
Sincerely,
Bill